Exact Mass: 305.0122644
Exact Mass Matches: 305.0122644
Found 37 metabolites which its exact mass value is equals to given mass value 305.0122644
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
2-[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]aniline
3-Bromo-N-(tert-butyl)-5-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
n-t-butyl 3-bromo-4-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
7-BROMO-1,2,3,4-TETRAHYDRO-ACRIDINE-9-CARBOXYLICACID
2-(4-methoxy-phenyl)-imidazo[1,2-a]pyrimidine monohydrobromine
3-chloro-5-cyclopropyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxylic acid
2-Bromo-N-pentylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
3-(6-Bromopyridin-2-yl)-4-methyl-benzoic acid methyl ester
[2-(5-BROMO-THIOPHEN-2-YL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER
C11H16BrNO2S (305.00850560000003)
4-CYANO-3-(4-METHOXYPHENYL)-5-(METHYLTHIO)THIOPHENE-2-CARBOXYLIC ACID
5-bromo-N-(tert-butyl)-2-Methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
3-Bromo-N-butyl-5-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
3-Bromo-N-(tert-butyl)-N-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
4-Bromo-N-(tert-butyl)-3-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
3-bromo-N,N-diethyl-4-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
3-Bromo-N,N-diethyl-5-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
4-Bromo-N,N-diethyl-3-methylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
N-BUTYL 3-BROMO-4-METHYLBENZENESULFONAMIDE
C11H16BrNO2S (305.00850560000003)
3-Bromo-N-pentylbenzenesulfonamide
C11H16BrNO2S (305.00850560000003)
2,3-cyclic UMP(1-)
C9H10N2O8P- (305.01747700000004)
A 2,3-cyclic nucleotide(1-) which is obtained from 2,3-cyclic UMP by removal of a proton from the cyclic phosphate group.
5-((5-(4-Fluoro-2-hydroxyphenyl)furan-2-yl)methylene)thiazolidine-2,4-dione
5-[(1,3-Benzothiazol-2-ylthio)methyl]-2-furancarboxylic acid methyl ester
Taminadenant
Taminadenant (NIR178; PBF509) is a highly potent and orally active adenosine A2A receptor (A2AR) antagonist. Taminadenant can antagonize A2AR agonist-mediated cAMP accumulation and impedance responses with KB values of 72.8 nM and 8.2 nM, respectively. Taminadenant reverses motor impairments in several rat models of movement disorders, including catalepsy, tremor, and hemiparkinsonism. Taminadenant can also inhibit tumor growth when combined with Spartalizumab (HY-P9972). Taminadenant reactivate the antitumor immune response[1][2].